‘Cold caps’ may halt hair loss in breast cancer patients: study

‘Cold caps’ may halt hair loss in breast cancer patients: study
16:34 14 Dekabr 2016
Ölkə mətbuatı
A- A+

Cooling the scalp with a specialized cap during chemotherapy sessions could help breast cancer patients avoid treatment-related hair loss, new research suggests.
 
In a clinical trial involving women with early stage breast cancer, just over half who underwent scalp-cooling throughout at least four cycles of chemotherapy retained their hair, though some thinning may have occurred.
 
"When you lose your hair, everyone knows you're sick and looks at you differently," said study author Dr. Julie Rani Nangia, explaining the potential impact of cold cap use.
 
Nangia is an assistant professor of medicine at the Lester and Sue Smith Breast Center at Baylor College of Medicine in Houston.
 
The study was funded by the manufacturer of the cold caps, Paxman Cooling. The devices are known as the Orbis Paxman Hair Loss Prevention System. The company is now seeking U.S. Food and Drug Administration clearance for their cold caps.
 
Nearly 247,000 women have been diagnosed with breast cancer in the United States this year, according to the American Cancer Society. There are also about 2.8 million breast cancer survivors in the United States.
 
Treatment depends on the stage and aggressiveness of a patient's cancer. Treatment can include surgery, chemotherapy, radiation and/or hormone and targeted therapies.
 
Nangia and her team enrolled 235 women with stage 1 or stage 2 breast cancer who were planning to receive at least four cycles of anthracycline- or taxane-based chemotherapy. Those chemotherapy drugs, like others, can lead to hair loss because they attack rapidly dividing cells, which include cancer cells but also hair follicles.
 
Scalp cooling, more commonly used in Europe, is believed to reduce hair loss by lowering the temperature of the scalp, reducing blood flow to hair follicles. Another brand of cold cap known as the DigniCap was cleared for use in the United States by the FDA in December 2015.
 
In the new study, participants were split into two groups. One group included two-thirds of the women. This group received scalp cooling. The other third received no cooling.
 
After four cycles of chemotherapy, 50.5 percent of patients in the cooling group experienced hair preservation, compared with none in the non-cooling group, the study findings showed.
 
Fitted to a patient's head, the cold caps were in place 30 minutes before chemotherapy began, for the entire chemotherapy session, and for 90 minutes after chemotherapy, Nangia explained. The cold cap cooled patients' scalps to 64 degrees, she said, and side effects were mild, including headache and discomfort.
 
"The big downside is it adds an hour onto [total] chemotherapy time," Nangia said. She noted that the difficulty of perfecting the fit of a cap to each patient's head may have influenced how effectively it thwarted hair loss.
 
Scalp-cooling technology has been used during treatment for other solid tumor cancers in other countries, but isn't recommended for patients with blood cancers because it constricts blood vessels. Women in this study will be tracked for the next five years to monitor overall survival, any cancer recurrence and potential spread of cancer to the scalp, Nangia said.
 
Susan Brown is managing director of health and science education for the nonprofit breast cancer advocacy group Susan G. Komen. She said she was somewhat surprised by the study findings, noting that other research on cold caps has produced "varying degrees of success in hair retention."
 
Brown said the cost of cold caps—which can exceed $1,000 per patient, according to Nangia—might pose an obstacle for some patients. Wigs are likely cheaper and sometimes paid for by grants and other funding sources, Brown added.
 
But Brown believes cold caps could be an important option for women with breast cancer, though probably not all would want to use them.
 
"If women don't have to lose their hair, it helps them personally and emotionally, and leaves it to them to share their story if they want to," she said.
 
The study was scheduled for presentation Friday at the San Antonio Breast Cancer Symposium in Texas. Research presented at scientific meetings typically hasn't been peer-reviewed or published, and results are considered preliminary.


RƏYLƏR

OXŞAR XƏBƏRLƏR

BU KATEQORİYADAN DİGƏR XƏBƏRLƏR

Ölkə mətbuatında bugün »

Britaniyada terror təhlükəsinin səviyyəsi yüksəldi

24 May 2017 04:34

Cocuq Mərcanlıda tank əleyhinə mina və qumbara tapıldı

24 May 2017 04:33

Gözəl Emili - FOTO

24 May 2017 04:32

Ağ Ev: Terrorizmə qarşı koalisiya bütün dinlərin vəzifədir

24 May 2017 04:29

ABŞ raket müdafiə sisteminə 10 mlrd. dollar ayırır

24 May 2017 04:09

"28 May" metrostansiyası qarşısında bıçaqlanma olub

24 May 2017 04:07

Zəvvarları daşıyan avtobus qəzaya uğradı:

24 May 2017 03:41

9 minə yaxın “Jeep” geri çağırıldı - SƏBƏB?

24 May 2017 03:33

Helena yaya hazırlaşır - FOTO

24 May 2017 03:32

Bakıda 38 yaşlı kişi özünü bıçaqlayaraq intihar etmək istəyib

24 May 2017 02:42

Ağcabədidə traktor yanıb

24 May 2017 02:36

İran saytında Bakı haqqında FOTOSESSİYA

24 May 2017 02:33

Küllücə tufliləri - FOTO

24 May 2017 02:32

Rusiyaya səfərini yarımçıq qoyacaq -

24 May 2017 02:32

28 May-Respublika Günü Tehranda qeyd edildi

24 May 2017 02:24

Cocuq Mərcanlıda tank əleyhinə mina və partlamamış hərbi sursat aşkar edilib

24 May 2017 02:12

ÜST-ə yeni rəhbər gəldi

24 May 2017 02:04

Ağcabədidə traktor yanıb

24 May 2017 01:54

Putin Filippin prezidenti ilə görüşür

24 May 2017 01:50

Ümumdünya Səhiyyə Təşkilatına yeni baş direktor seçilib

24 May 2017 01:47

“Beynəlxalq Bank 2018-ci ildən tez özəlləşdirilməyəcək” -

24 May 2017 01:41

Britaniyada terror təhlükəsi səviyyəsi kritik həddə qaldırılıb

24 May 2017 01:32

Ən məşhur moda şousunun qonaqları - FOTO

24 May 2017 01:32

Keçmiş arvadının evini yandıran ər: “Həmişə içkili oluram...” - FOTO/VİDEO

24 May 2017 01:28

"Mançester Yunayted" ulduz futbolçuya görə illik 14 milyonundan keçməyə hazırdı

24 May 2017 01:28

Quba sakinlərini hamamda boğub, cəsədlərini çaya atdılar - FOTO

24 May 2017 01:03

Cocuq Mərcanlıda tank əleyhinə mina və qumbara aşkarlanıb

24 May 2017 00:57

Ermənistanın təhlükəsi yenidən Avropanın diqqət mərkəzində

24 May 2017 00:49

Filippin prezidenti Rusiyaya rəsmi səfərini yarımçıq qoyub

24 May 2017 00:47

Venesuelada prezidentə qarşı etiraz aksiyalarında ölənlərin sayı 55-ə çatıb

24 May 2017 00:42

Bakıda 80 yaşlı qadın oğlu tərəfindən qəddarcasına döyülüb

24 May 2017 00:37

Cənubi Koreya-Şimali Koreya sərhədində silah səsləri eşidildi

24 May 2017 00:26

Biləsuvar RMX-nın baş həkimi işdən azad olundu

24 May 2017 00:24

123 mərtəbəli göydələndə dəhşətli anlar - VİDEO

24 May 2017 00:23

Afaq, Nərgiz və Tolik Bodrumda dincəlir - FOTO

24 May 2017 00:12

Astroloji proqnoz - 24 may

24 May 2017 00:08

Əlidən etiraf: "Kaş ki..." - VİDEO

24 May 2017 00:05

Günün qoroskopu: əsəb sisteminizə çox yük düşür

24 May 2017 00:05

Birmingemdə aksiya zamanı əlində bıçaq və dəyənək olan şəxs saxlanılıb

23 May 2017 23:57

Üz üçün “Minus 10" maskası

23 May 2017 23:57

Trampla çəkdirdiyi "selfi" israilli deputatın başına bəla oldu -

23 May 2017 23:56

Üç qız atası ilə evlənən 49 yaşlı xalq artistinin TOYUNDA NƏLƏR BAŞ VERDİ?

23 May 2017 23:53

Qarın bölgəsindəki pylərdən xilas edən içki

23 May 2017 23:52

Adams, Messi, Vardi... – Qanunsuzluğa əl atanlar

23 May 2017 23:52

Saçların yağlanmasına gətirən 6 səbəb

23 May 2017 23:47

Bu 3 dəstə İmam Zaman ağaya yardım edəcək

23 May 2017 23:42

"Barselona"nın sükanı arxasına keçəcək baş məşqçi hazırkı komandasından istefa verib

23 May 2017 23:37

Böyrək daşları və xalq təbabəti

23 May 2017 23:37

"Azərbaycan Beynəlxalq Bankı 2018-ci ildən tez özəlləşdirilməyəcək" - Nazir

23 May 2017 23:32

Məşhur gözəl Kann təqdimatında - FOTO

23 May 2017 23:32